Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes

Diabetes

Volumn 48, Issue 9, 1999, Pages 1807-1814

  Friedman, Jacob E ^a,b   Ishizuka, Tatsuya ^a   Shao, Jianhua ^a   Huston, Larraine ^a   Highman, Timothy ^a   Catalano, Patrick ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; ARTICLE; AUTOPHOSPHORYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESISTANCE; MUSCLE LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RISK; SKELETAL MUSCLE;

ADULT; BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HUMANS; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; PREGNANCY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0032848778     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.9.1807     Document Type: Article

References (55)

1. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA: Longitudinal changes in insulin resistance and insulin release in non-obese pregnant women. Am J Obstet Gynecol 165:1667-1671, 1991
2. Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, Sims EAH: Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264:E60-E67, 1993
3. Barden TP, HC Knowles: Diagnosis of diabetes in pregnancy. Clin Obstet Gynecol 24:3-19, 1981
4. Buchanan TA, Metzger BE, Freinkel N, Bergman RN: Insulin sensitivity and beta cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008-1014, 1990
5. Kuhl C: Insulin secretion and insulin resistance in pregnancy and GDM. Diabetes 40 (Suppl. 2):18-24, 1991
6. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B: Pronounced insulin resistance and inadequate β-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723, 1997
7. Ryan EA, O'Sullivan MJ, Skyler JS: Insulin action during pregnancy: studies with the euglycemic clamp technique. Diabetes 34:380-389, 1985
8. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B: Pronounced insulin resistance and inadequate β-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723, 1997
9. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM: Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes 42: 1773-1785, 1993
10. Kjos SL, Peters RK, Xiang A, Henry OA, Motoro M, Buchanan TA: Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 44:586-591, 1995
11. Hagbard L, Svanborg A: Prognosis of diabetes mellitus with onset during pregnancy: a clinical study of 71 cases. Diabetes 9:296-302, 1960
12. O'Sullivan JB: Body weight and subsequent diabetes mellitus. JAMA 248: 949-952, 1982
13. Kasuga M, Karlsson FA, Kahn CR: Insulin stimulates the phosphorylation of the β-subunit of its own receptor. Science 217:185-187, 1982
14. White MF, Shoelson SE, Keutmann E, Kahn CR: A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 263:2969-2980, 1988
15. Wilden PA, Siddle K, Haring HE, Backer JM, White MF, Kahn CR: The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities: analysis with insulin and anti-receptor antibodies. J Biol Chem 267: 13719-13726, 1992
16. Tamemoto H, Kadowaki T, Tobe K, Takeshi Y, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S: Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186, 1994
17. Araki E, Lipes MA, Patti ME, Bruning JC, Hagg B, Johnson RS, Kahn CR: Alternative pathway for insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 72:186-189, 1994
18. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1-4, 1994
19. Holman GD, Kasuga M: From receptor to transporter: insulin signaling to glucose transport. Diabetologia 40:991-1003, 1997
20. Backer JM, Myers MG, Shoelson SE, Chin DE, Sun XJ, Mirapleix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF: Phosphatidylinositol 3′ kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479, 1992
21. Herbst JJ, Andrews GC, Contillo LG, Singleton DH, Genereux PE, Gibbs ME, Lienhard GE: Effect of the activation of phosphatidylinositol 3-kinase by a thiolphosphotyrosine peptide on glucose transport in 3T3-L1 adipocytes. J Biol Chem 270:26000-26005, 1995
22. Wiese RJ, Mastick CC, Lazar DF, Saltiel AR: Activation of mitogen-activated protein kinase and phosphatidylinositol 3′ kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes. J Biol Chem 270:3442-3446, 1995
23. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A: Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41:465-475, 1992
24. Dohm GL, Elton CW, Friedman JE, Pilch PF, Pories WJ, Atkinson SM, Caro JF: Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol 260:E459-E463, 1991
25. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB: Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865-870, 1990
26. Dohm GL, Tapscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim D, Fushiki T, Atkinson SM, Elton CW, Caro JF: An in vitro human muscle preparation suitable for metabolic studies: decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 82:486-494, 1988
27. Zierath JR: In vitro studies of human skeletal muscle: hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 155:1-96, 1995
28. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm G: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79:1330-1337, 1987
29. Obermaier-Kusser B, White MF, Pongrato DE, Su Z, Ermel B, Mulbacher C, Haring HU: A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin dependent diabetes mellitus. J Biol Chem 264: 9497-9504, 1989
30. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of non-insulin dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78:471-477, 1994
31. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195-2204, 1995
32. Bjornholm M, Kawano Y, Lehtihet M, Zierath JR: Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527, 1997
33. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes 28:1039-1057, 1979
34. Catalano PM, Wong WW, Drago NM, Amini SB: Estimating body composition in late gestation: a new hydration constant for body density and total body water. Am J Physiol 268:E153-E158, 1995
35. Drago NM, Wong W, Amini SB, Catalano PM: Anthropometric estimation of maternal body composition in late gestation (Abstract). J Soc Gynecol Invest 2:300, 1995
36. Smigaj D, Roman-Drago NM, Amini SB, Caritis SN, Kalhan SC, Catalano PM: The effect of oral terbutaline on maternal glucose metabolism and energy expenditure in pregnancy. Am J Obstet Gynecol 178:1041-1047, 1998
37. Friedman JE, Dohm GL, Leggett N, Pories WJ, Caro JF: Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss: effect of muscle glucose transport and glucose transporter GLUT4. J Clin Invest 89:701-705, 1992
38. Bonadonna RC, Saccomani MP, Seely L, Zych K, Ferrannini E, Cobelli C, DeFronzo RA: Glucose transport in human skeletal muscle: the in vivo response to insulin. Diabetes 42:191-198, 1993
39. Ziel FH, Venkatesan N, Davidson MB: Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37:855-390, 1988
40. Katz A, Nyomba BL, Bogardus C: No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol 255: E942-E945, 1990
41. Bogardus C, Lillioja S, Mott D, Reaven GR, Kashiwagi A, Foley JE: Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 73:800-805, 1984
42. Catalano PM, Huston L, Amini SB, Kalhan SC: Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Ob Gyn 180:903-916, 1999
43. Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredickson A, Beattie J, Theriault R: The effect of non-insulin dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705-2713, 1996
44. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Transmembrane glucose transport in skeletal muscle of patients with non-insulin dependent diabetes. J Clin Invest 92: 486-494, 1993
45. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI: Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Nat Acad Sci U S A 92:983-987, 1995
46. Rondinone CM, Wand LM, Lonnroth P, Wesslau C, Pierce JH, Smith U: Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Nat Acad Sci U S A 94:4171-4175, 1997
47. Shepherd PR, Nave BT, Rincon J, Nolte LA, Bevan AP, Siddle K, Zierath JR, Wallberg-Henrikson H: Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle. J Biol Chem 272:19000-19007, 1997
48. Saad MJA, Maeda L, Brenelli SL, Carvalho CRO, Paiva RS, Velloso LA: Defects in insulin signal transduction in liver and muscle of pregnant rats. Diabetologia 40:179-186, 1997
49. Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ: Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 91:2020-2030, 1993
50. Saad MJ, Folli F, Kahn JAA, Kahn CR: Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072, 1993
51. Damm P, Handberg A, Kuhl C, Beck-Nielsen H, Molsted-Pedersen L: Insulin receptor binding and tyrosine kinase activity in skeletal muscle from normal pregnant women and women with gestational diabetes. J Obstet Gynecol 82: 251-259, 1993
52. Flier JS: The insulin receptor. In Diabetes Mellitus. Leroith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott-Raven, 1996, p. 148-154
53. Thies RS, Ulrich A, McClan DA: Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem 264:12820-12825, 1989
54. Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Tyzbir E, Sims EAH: Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol 155:1255-1262, 1986
55. Ryan EA, Imes S, Dating L, McManus R, Finegood DT, Polonsky KS, Sturis J: Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44:506-512, 1995